Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials

por Cai SL, Lu HF, Bai ZH, Wu RR, Zhao JP
Publicado 2015

Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral a...

por Li N, Feng Y, Lu HF, Cai SL, Zhuo JM, Si TM, Zhang LL
Publicado 2018

A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer

por Yalikong A, Li XQ, Zhou PH, Qi ZP, Li B, Cai SL, Zhong YS
Publicado 2021

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study

por Zhao JP, Li LH, Shi JG, Li Y, Xu XF, Li KQ, Zhang LL, Cai SL, Feng Y, Zhuo JM, Liu WH, Lu HF
Publicado 2017